Immunocore Holdings (IMCR) Assets Average (2020 - 2026)

Immunocore Holdings has disclosed Assets Average across 6 years of filings, most recently posting $1.1 billion for Q1 2026.

• Assets Average for Q1 2026 came in at $1.1 billion, up 5.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.1 billion (up 5.0% YoY), and the FY2025 annual result was $1.0 billion, up 29.27% from the prior year.
• Assets Average came in at $1.1 billion for Q1 2026 at Immunocore Holdings, down from $1.1 billion in the prior quarter.
• In the past five years, Assets Average ranged from a high of $1.1 billion in Q3 2025 to a low of $458.8 million in Q4 2022.
• The 4-year median for Assets Average is $1.1 billion (2024), against an average of $968.5 million.
• Across the five-year window, Assets Average surged 37.54% in 2022 and gained 3.61% in 2025, its largest moves.
• Immunocore Holdings' Assets Average stood at $458.8 million in 2022, then surged by 128.21% to $1.0 billion in 2024, then rose by 3.61% to $1.1 billion in 2025, then declined by 1.4% to $1.1 billion in 2026.
• The last three Assets Average figures came in at $1.1 billion (Q1 2026), $1.1 billion (Q4 2025), and $1.1 billion (Q3 2025), per Business Quant data.